Evaluation of safety and efficacy of adipose-derived stem cells in rat myocardial infarction model using hexadecyl-4-[124I]iodobenzoate for cell tracking

  • Min Hwan Kim
  • , Kyo Chul Lee
  • , Gwang Il An
  • , Sang Keun Woo
  • , Noh Won Park
  • , Byung Il Kim
  • , Ki Dong Eom
  • , Kwang Il Kim
  • , Tae Sup Lee
  • , Chan Wha Kim
  • , Jeongsoo Yoo
  • , Joo Hyun Kang
  • , Yong Jin Lee*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    Abstract

    This study was aimed to evaluate the effect of 124I-labeling with hexadecyl-4-iodobenzoate (HIB) on gene expression related to cell cycle, DNA repair, transcription, proliferation and differentiation of adipose-derived stem cells (ADSCs). [124I]HIB showed high labeling efficiency with ADSCs (51.3±1.3%, 0.3-2.0Bq/cell) and there is no morphological change of ADSCs. In the microarray analysis of gene expression pattern, differences were not observed between non-labeled and [124I]HIB-labeled ADSCs. We demonstrated that 124I-labeling with HIB did not affect the biological properties of ADSCs.

    Original languageEnglish
    Pages (from-to)116-123
    Number of pages8
    JournalApplied Radiation and Isotopes
    Volume108
    DOIs
    Publication statusPublished - 2016 Feb 1

    Bibliographical note

    Publisher Copyright:
    © 2015 Elsevier Ltd.

    Keywords

    • Adipose-derived stem cells
    • Direct labeling agent
    • Hexadecyl-4-[I]iodobenzoate
    • Microarray
    • Myocardial infarction

    ASJC Scopus subject areas

    • Radiation

    Fingerprint

    Dive into the research topics of 'Evaluation of safety and efficacy of adipose-derived stem cells in rat myocardial infarction model using hexadecyl-4-[124I]iodobenzoate for cell tracking'. Together they form a unique fingerprint.

    Cite this